The FDA has issued an alert regarding a safety concern with certain Boston Scientific defibrillator leads used in implantable cardioverter defibrillators. The affected models include Endotak Reliance, ...

Cardiology is undergoing a year of rapid change, driven by innovations that are expanding diagnostic capabilities, advancing treatment options and personalizing care. From artificial intelligence and ...

Two professional societies issued the first major set of evidence-based guidelines to define best practices in the use of ...

The advantage over balloon angioplasty in this higher-risk subset was consistent with the results seen in single-layer ISR.

The shares of biotech companies fell after news that ousted regulator Vinay Prasad is set to go back to the US Food and Drug Administration. Prasad had previously overruled his own scientific review ...

Surmodics, Inc. SRDX delivered adjusted earnings per share (EPS) of 6 cents in the third quarter of fiscal 2025 against the ...

The demand for erectile dysfunction devices is largely fueled by the growing incidence of ED, especially among men with chronic health conditions lik ...

Speaking at a DGDA press briefing this morning (12 August), he said prices of 10 types of stents from three companies, Abbott, Boston Scientific and Medtronic, have already been reduced, with the new ...

Insulet Corporation PODD reported second-quarter 2025 adjusted earnings per share (EPS) of $1.17, up 112.7% from the year-ago ...

Detailed price information for Medpace Holdings Inc (MEDP-Q) from The Globe and Mail including charting and trades.

Cryofocus Medtech (Shanghai) Co., Ltd. ("Cryofocus" or the "Company," Stock Code: 6922.HK), a global innovator in minimally invasive interventional cryotherapy, last friday announced its unaudited ...